Analyzing heart and kidney outcomes after canagliflozin treatment in older adults
byAmerican Society of NephrologyCredit: Unsplash/CC0 Public DomainSodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2
Updated on: November 05,2024
0

Analyzing heart and kidney outcomes after canagliflozin treatment in older adults
byAmerican Society of NephrologyCredit: Unsplash/CC0 Public DomainSodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2
Updated on:November 05,2024
0
